Handling Covariates in the Design of Clinical Trials.
暂无分享,去创建一个
[1] Richard L. Smith. Properties of Biased Coin Designs in Sequential Clinical Trials , 1984 .
[2] J H Klotz. Maximum entropy constrained balance randomization for clinical trials. , 1978, Biometrics.
[3] A. Atkinson,et al. Adaptive biased‐coin designs for skewing the allocation proportion in clinical trials with normal responses , 2005, Statistics in medicine.
[4] F. Pesarin. Multivariate Permutation Tests : With Applications in Biostatistics , 2001 .
[5] John Lewis,et al. Adjustment for baseline covariates: an introductory note. , 2004, Statistics in medicine.
[6] Alessandra Giovagnoli,et al. On the Large Sample Optimality of Sequential Designs for Comparing Two or More Treatments , 2005 .
[7] Richard L. Smith. Sequential Treatment Allocation Using Biased Coin Designs , 1984 .
[8] Mitchell H. Gail,et al. A conversation with Nathan Mantel , 1997 .
[9] Uttam Bandyopadhyay,et al. Adaptive designs for normal responses with prognostic factors , 2001 .
[10] A. Atkinson. Optimum biased coin designs for sequential clinical trials with prognostic factors , 1982 .
[11] A. Atkinson,et al. Optimum biased-coin designs for sequential treatment allocation with covariate information. , 1999, Statistics in medicine.
[12] J. Matthews,et al. Randomization in Clinical Trials: Theory and Practice; , 2003 .
[13] Klotz Jh,et al. Maximum entropy constrained balance randomization for clinical trials. , 1978 .
[14] Marion K Campbell,et al. The method of minimization for allocation to clinical trials. a review. , 2002, Controlled clinical trials.
[15] Feifang Hu,et al. Asymptotic properties of doubly adaptive biased coin designs for multitreatment clinical trials , 2003 .
[16] J. Kiefer,et al. The Equivalence of Two Extremum Problems , 1960, Canadian Journal of Mathematics.
[17] C B Begg,et al. A treatment allocation procedure for sequential clinical trials. , 1980, Biometrics.
[18] Orjan Nordle,et al. A self‐adjusting randomization plan for allocation of patients into two treatment groups , 1977, Clinical pharmacology and therapeutics.
[19] A. Satterfield,et al. TREATMENT , 1924, California and western medicine.
[20] T M Therneau,et al. How many stratification factors are "too many" to use in a randomization plan? , 1993, Controlled clinical trials.
[21] Herman Chernoff,et al. Forcing a Sequential Experiment to be Balanced , 2008 .
[22] Erling B. Andersen,et al. Asymptotic Properties of , 1970 .
[23] W. Rosenberger,et al. COVARIATE-ADJUSTED RESPONSE-ADAPTIVE DESIGNS FOR BINARY RESPONSE , 2001, Journal of biopharmaceutical statistics.
[24] Atanu Biswas,et al. Bayesian Adaptive Biased‐Coin Designs for Clinical Trials with Normal Responses , 2005, Biometrics.
[25] Jean Coope,et al. The Impact of Treatment , 1996 .
[26] C B Begg,et al. Treatment allocation methods in clinical trials: a review. , 1985, Statistics in medicine.
[27] M Zelen,et al. The randomization and stratification of patients to clinical trials. , 1974, Journal of chronic diseases.
[28] L A Kalish,et al. Efficiency of balanced treatment allocation for survival analysis. , 1988, Biometrics.
[29] N. Birkett,et al. Adaptive allocation in randomized controlled trials. , 1985, Controlled clinical trials.
[30] Damian McEntegart,et al. The Pursuit of Balance Using Stratified and Dynamic Randomization Techniques: An Overview , 2003 .
[31] D. Taves,et al. Faulty assumptions in Atkinson's criteria for clinical trial design , 2004 .
[32] C B Begg,et al. The impact of treatment allocation procedures on nominal significance levels and bias. , 1987, Controlled clinical trials.
[33] Mikel Aickin,et al. Randomization, balance, and the validity and efficiency of design-adaptive allocation methods , 2001 .
[34] W. Rosenberger,et al. The theory of response-adaptive randomization in clinical trials , 2006 .
[35] Anthony C. Atkinson,et al. The comparison of designs for sequential clinical trials with covariate information , 2002 .
[36] S. Pocock,et al. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. , 1975, Biometrics.
[37] James Frane,et al. A Method of Biased Coin Randomization, Its Implementation, and Its Validation , 1998 .
[38] Stephane Heritier,et al. Dynamic balancing randomization in controlled clinical trials , 2005, Statistics in medicine.
[39] N Stallard,et al. Optimal Adaptive Designs for Binary Response Trials , 2001, Biometrics.
[40] L. J. Wei,et al. An Application of an Urn Model to the Design of Sequential Controlled Clinical Trials , 1978 .
[41] J. Grizzle,et al. A note on stratifying versus complete random assignment in clinical trials. , 1982, Controlled clinical trials.
[42] Dongsheng Tu,et al. Adjustment of Treatment Effect for Covariates in Clinical Trials: Statistical and Regulatory Issues , 2000 .
[43] Val Gebski,et al. Dynamic balanced randomization for clinical trials , 1993 .
[44] C. Begg,et al. Treatment allocation for nonlinear models in clinical trials: the logistic model. , 1984, Biometrics.
[45] David A. Harville,et al. Nearly Optimal Allocation of Experimental Units Using Observed Covariate Values , 1974 .
[46] Isabella Verdinelli,et al. Biased coin designs with a Bayesian bias , 1993 .
[47] T. Treasure,et al. Minimisation: the platinum standard for trials? , 1998, BMJ.
[48] Brian Leyland-Jones,et al. Breast cancer trial with erythropoietin terminated unexpectedly. , 2003, The Lancet. Oncology.
[49] Uttam Bandyopadhyay,et al. A covariate adjusted two‐stage allocation design for binary responses in randomized clinical trials , 2007, Statistics in medicine.
[50] Titterington Dm,et al. On constrained balance randomization for clinical trials. , 1983 .
[51] Claudio J. Verzilli,et al. Adjustment for Covariates , 2006 .
[52] Li-Xin Zhang,et al. Asymptotic properties of covariate-adjusted response-adaptive designs , 2006 .
[53] Damaraju Raghavarao. Use of Distance Function in Sequential Treatment Assignment for Prognostic Factors in the Controlled Clinical Trial , 1980 .
[54] D R Taves,et al. Minimization: A new method of assigning patients to treatment and control groups , 1974, Clinical pharmacology and therapeutics.